Jagsonpal PharmaceuticalsJAGSNPHARM 
$4.78-2.58%24h
-2.58%24h
Global rank20040
Market cap$125.13M
Change 7d5.53%
YTD Performance2.44%
SP500 benchmarkUnderperform
P/E0.47
P/S4.43
Revenue$28.22M
Earnings$3.19M
Dividend yield-
Main Sector
Healthcare
Category
Jagsonpal Pharmaceuticals (JAGSNPHARM) Cash on Hand
JAGSNPHARM Cash on Hand in 2022: $13.68M
According to Jagsonpal Pharmaceuticals latest financial reports the cash on hand of JAGSNPHARM is $13.68M, an increase of 142.00% to 2022. At the end of 2022 company had $5.65M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
JAGSNPHARM Cash on Hand History from 2019 to 2023
-
Value:-
JAGSNPHARM Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $13.68M | 142.00% |
| 2022 | $5.65M | -26.14% |
| 2021 | $7.65M | 62.32% |
| 2020 | $4.71M | 2.60% |
| 2019 | $4.59M | - |
View the Top Cash on Hand Companies 
